• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Nizoral (Ketoconazole) 2% Shampoo

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

October 2013

Summary View

PRECAUTIONS

Information for Patients
  • The following have been reported with the use of Nizoral (ketoconazole) 2% Shampoo: angioedema
  • Patients who develop allergic reactions, such as angioedema

OVERDOSAGE

  • Induced emesis and gastric lavage should not be performed to avoid aspiration. 

 

December 2012

Summary View 

ADVERSE REACTIONS

  • Alopecia